Caution: Kodak's comeback may not be picture-perfect

Aug 7, 2020
The Trump administration has given Kodak hundreds of millions of dollars to produce chemicals for COVID-19 treatments. But the venerable photography company will have to compete with a global supply chain.
Kodak once could claim the majority of the global film market. Now, it's being tapped to produce chemicals for potential COVID-19 treatments.
Chris Furlong/Getty Images

U.S. and EU vaccine deals raise fears of 'vaccine nationalism'

Jul 31, 2020
What does it mean for the rest of the world if countries have dibs on vaccine doses?
President Donald Trump tours a North Carolina lab making components for a potential vaccine. The U.S. has struck deals with drug companies for access to coronavirus vaccines in development.
Jim Watson/AFP via Getty Images

Prescription drug supply could be hit by COVID-19

Feb 26, 2020
China plays a big part in the supply chain of Americans' generic drugs
COVID-19 could affect the supply of prescription drugs worldwide.
Dale de la Rey/AFP via Getty Images

New gene therapy drug expected to hit market with head-spinning price tag

May 22, 2019
Industry analysts expect the price for the single-treatment therapy to be anywhere from $1.5 million to $5 million.
Swiss pharmaceutical giant Novartis' Basel headquarters.
SEBASTIEN BOZON/AFP/Getty Images

Would requiring prices in pharmaceutical ads make drugs cheaper?

Apr 9, 2019
The idea is that transparency would lead to more competition and lower costs. One drug company is already on board.
Philippe Huguen/AFP/Getty Images

Walgreens has a tough quarter

Apr 2, 2019
Pharmacy chain Walgreens reported a 3.8 percent drop in sales for the quarter. The company cited a weak cough, cold and flu season — and declining profits from generic and branded prescription drugs. Click the audio player above to hear the full story.
People walk by a Walgreens store in San Francisco. The pharmacy industry thinks bigger is better to find cost savings.
Justin Sullivan/Getty Images

You’ve got questions. We help you answer them.

Support nonprofit, independent journalism that makes you smarter.

FDA approves new Johnson & Johnson drug for depression

Mar 6, 2019
The Food and Drug Administration has approved the first new kind of drug to treat depression since Prozac hit the scene in the late 1980s. Spravato is a nasal spray from Johnson & Johnson that’s a close cousin of ketamine, an anesthetic that’s sometimes used recreationally and often known as “Special K.” Because ketamine can cause […]
Janssen Pharmaceutica

Kickbacks or a helpful service? Here's why pharma is under fire

Sep 21, 2018
Drug companies can get creative with doctor incentives, and that can be problematic.
A pharmacy technician counts out a prescription of antibiotic pills.
Joe Raedle/Getty Images

House passes measure giving terminally ill patients more access to experimental drugs

May 23, 2018
More patients who are terminally ill will potentially have access to experimental drugs under a measure passed by the House last night. President Donald Trump is expected to sign the so-called “right-to-try” bill. Forty states have already passed similar legislation. Currently, terminal patients not covered by those laws have only two options for getting unapproved […]